The Chemours Co. Hits New 52-Week High at $27.51

The Chemours Co., a player in the specialty chemicals industry, has reached a significant milestone by hitting a new 52-week high of USD 27.51 on April 30, 2026. This achievement marks a notable increase from its 52-week low of USD 9.13, reflecting a substantial upward trend in its stock performance over the past year. Despite a 12.62% increase in its stock price over the last year, The Chemours Co. has underperformed compared to the S&P 500, which has seen a 29.45% rise during the same period. The company's market capitalization stands at USD 3,138 million, categorizing it as a small-cap stock. Financial metrics indicate a dividend yield of 1.67%, while the company's debt-to-equity ratio is reported at 13.88. However, it is important to note that The Chemours Co. is currently loss-making, with a return on equity of -4.80% and a price-to-book ratio of 12.55. This recent price movement underscores the dynamic nature of the specialty chemicals sector and the company's position within it.